HIGHLIGHTS
- who: Ninghua Yao from the (UNIVERSITY) have published the article: An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma, in the Journal: (JOURNAL)
- what: The authors identified and validated a robust IGS through multi-step processes using multiple databases (Fig 8).
- how: The authors developed and validated a robust risk model for HCC which could predict the prognosis of HCC patients and the response of immunotherapy. The authors compared the performance of the IGS risk model with 4 previous immune-related signatures in the CHCC cohort. The result . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.